Peter F Deblasio Jr, MD | |
1532 Smith St, North Providence, RI 02911-2939 | |
(401) 353-5735 | |
(401) 353-1020 |
Full Name | Peter F Deblasio Jr |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 46 Years |
Location | 1532 Smith St, North Providence, Rhode Island |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174514210 | NPI | - | NPPES |
7001864 | Medicaid | RI | |
180000314 | Other | RI | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | RI5407 (Rhode Island) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Our Lady Of Fatima Hospital | North providence, RI | Hospital |
Mailing Address | Practice Location Address |
---|---|
Peter F Deblasio Jr, MD 1532 Smith St, North Providence, RI 02911-2939 Ph: (401) 353-5735 | Peter F Deblasio Jr, MD 1532 Smith St, North Providence, RI 02911-2939 Ph: (401) 353-5735 |
News Archive
President Barack Obama is in excellent health and tobacco free, his doctor said Monday in the results of the president's second physical exam since taking office.
Since fast and accurate detection of potential conditions in the head, chest and abdomen can save lives in a hospital's emergency department (ED), clinicians need cutting-edge CT technology to evaluate patients. To demonstrate the effectiveness of advanced CT imaging in the ED, Toshiba America Medical Systems, Inc., will highlight its Aquilion ONE CT system at the American Society of Emergency Radiology (ASER) conference, Sept. 14-17, 2011, in Miami.
ProFibrix B.V., a leader in the development of innovative bioactive products to stop bleeding (hemostasis), today announced the start of its pivotal Phase III clinical trial with Fibrocaps (FINISH-3) in spine, liver, vascular and soft tissue surgery.
In a post in the Center for Global Development's (CGD) "Global Health Policy" blog, Owen Barder, a senior fellow and director for Europe at the CGD, reports on the results of a large Phase III clinical trial conducted in Africa on the malaria vaccine candidate RTS,S, published online in the New England Journal of Medicine on Friday.
A UCSF stem cell study conducted in mice suggests a novel strategy for treating damaged cardiac tissue in patients following a heart attack. The approach potentially could improve cardiac function, minimize scar size, lead to the development of new blood vessels - and avoid the risk of tissue rejection.
› Verified 7 days ago
Donald Vincent Fargnoli, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1358 Smith St, North Providence, RI 02911 Phone: 401-353-2525 Fax: 401-353-6792 |